Showing results (141-150 of 225) with videos related to

Sort By:
Pageof 23
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2011
[Surgical resection for elderly patient with skin invasion of breast cancer]Shuhei Suzuki, Kenichi Sakurai, Saki Nagashima, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 25, 2018
[A Case of Advanced Breast Cancer with Liver Metastasis Successfully Treated with Multi-Disciplinary]Masashi Sakagami, Tomohiro Hirano, Shuhei Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2017
[Intra-Cystic Mucinous Carcinoma of the Breast - A Case Report]Keita Adachi, Shuhei Suzuki, Yuki Masuo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[Successful treatment of neuroendocrine ductal carcinoma in situ with loco-regional therapy]Kenichi Sakurai, Shigeru Fujisaki, Tetsuyo Maeda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 6, 2019
[Usefulness of Automated Breast Ultrasound for Deciding on a Surgical Approach in a Patient with Breast Cancer- A Case Report]Yuna Suzuki, Kenichi Sakurai, Keita Adachi, et al.
Anticancer Research|October 25, 2017
Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic AgentsTomomi Sanomachi, Shuhei Suzuki, Kenta Kuramoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 13, 2025
[A Case of Thyroid Cancer Discovered Incidentally after Breast Cancer Surgery]Kenichi Sakurai, Shuhei Suzuki, Keita Adachi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 17, 2026
[Pleomorphic Invasive Lobular Carcinoma Developed after Surgery for Simultaneous Ipsilateral Multiple Cancers]Kenichi Sakurai, Shuhei Suzuki, Keita Adachi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 27, 2012
[Usefulness of endoscopic resection for phyllodes tumor of the breast]Kenichi Sakurai, Shigeru Fujisaki, Tetsuyo Maeda, et al.
Anticancer Research|December 7, 2016
Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to GemcitabineHiroyuki Takeda, Masashi Okada, Shuhei Suzuki, et al.
Pageof 23